JP2020011967A5 - - Google Patents

Download PDF

Info

Publication number
JP2020011967A5
JP2020011967A5 JP2019159348A JP2019159348A JP2020011967A5 JP 2020011967 A5 JP2020011967 A5 JP 2020011967A5 JP 2019159348 A JP2019159348 A JP 2019159348A JP 2019159348 A JP2019159348 A JP 2019159348A JP 2020011967 A5 JP2020011967 A5 JP 2020011967A5
Authority
JP
Japan
Prior art keywords
preparation according
external preparation
permeation
acid
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019159348A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020011967A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2020011967A publication Critical patent/JP2020011967A/ja
Publication of JP2020011967A5 publication Critical patent/JP2020011967A5/ja
Pending legal-status Critical Current

Links

JP2019159348A 2017-10-30 2019-09-02 爪白癬治療用の外用製剤 Pending JP2020011967A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017209136 2017-10-30
JP2017209136 2017-10-30

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019529667A Division JP6582158B1 (ja) 2017-10-30 2018-10-29 爪白癬治療用の外用製剤

Publications (2)

Publication Number Publication Date
JP2020011967A JP2020011967A (ja) 2020-01-23
JP2020011967A5 true JP2020011967A5 (cg-RX-API-DMAC7.html) 2021-12-02

Family

ID=66333195

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019529667A Active JP6582158B1 (ja) 2017-10-30 2018-10-29 爪白癬治療用の外用製剤
JP2019159348A Pending JP2020011967A (ja) 2017-10-30 2019-09-02 爪白癬治療用の外用製剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019529667A Active JP6582158B1 (ja) 2017-10-30 2018-10-29 爪白癬治療用の外用製剤

Country Status (14)

Country Link
US (1) US20210213002A1 (cg-RX-API-DMAC7.html)
EP (1) EP3705136A4 (cg-RX-API-DMAC7.html)
JP (2) JP6582158B1 (cg-RX-API-DMAC7.html)
KR (1) KR20200081432A (cg-RX-API-DMAC7.html)
CN (1) CN111295202B (cg-RX-API-DMAC7.html)
AU (1) AU2018358372A1 (cg-RX-API-DMAC7.html)
BR (1) BR112020008282A2 (cg-RX-API-DMAC7.html)
CA (1) CA3081163A1 (cg-RX-API-DMAC7.html)
IL (1) IL274100B2 (cg-RX-API-DMAC7.html)
MX (1) MX2020004491A (cg-RX-API-DMAC7.html)
RU (1) RU2020117569A (cg-RX-API-DMAC7.html)
SG (1) SG11202003820VA (cg-RX-API-DMAC7.html)
TW (1) TWI789448B (cg-RX-API-DMAC7.html)
WO (1) WO2019088005A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220119363A (ko) 2019-12-24 2022-08-29 가껭세이야꾸가부시기가이샤 에피나코나졸을 함유하는 의약
KR102217617B1 (ko) * 2020-08-14 2021-02-19 비엘엔에이치 주식회사 백선의 예방 또는 치료용 약학적 조성물
JP2022547755A (ja) * 2020-08-14 2022-11-16 ビーエルアンドエイチ カンパニー,リミテッド 白癬を防止又は処置するための医薬組成物
JP2023553010A (ja) 2020-12-03 2023-12-20 バテル・メモリアル・インスティテュート 非ウイルス性送達のためのポリマーナノ粒子およびdnaナノ構造組成物ならびに方法
JP2024516108A (ja) 2021-04-07 2024-04-12 バテル・メモリアル・インスティテュート 非ウイルス性担体を同定および使用するための迅速な設計、構築、試験、および学習技術
CN119654156A (zh) 2022-05-16 2025-03-18 玛路弘株式会社 白癣治疗用组合物
TW202519215A (zh) * 2023-08-02 2025-05-16 日商石原產業股份有限公司 甲癬用外用劑
WO2025072751A1 (en) 2023-09-29 2025-04-03 Battelle Memorial Institute Polymer nanoparticle compositions for in vivo expression of polypeptides
WO2025122954A1 (en) 2023-12-08 2025-06-12 Battelle Memorial Institute Use of dna origami nanostructures for molecular information based data storage systems

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4514385A (en) * 1981-10-05 1985-04-30 Alcon Laboratories, Inc. Anti-acne compositions
JPS58162514A (ja) * 1982-03-19 1983-09-27 Sumitomo Chem Co Ltd 外用ゲル製剤
AU618517B2 (en) * 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
WO1995009007A1 (en) * 1993-09-29 1995-04-06 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutynin
EP1143950B1 (de) * 1998-09-10 2005-03-09 BioEqual AG Topisch anwendbare mittel gegen nagelpilzerkrankungen
US7384650B2 (en) * 1999-11-24 2008-06-10 Agile Therapeutics, Inc. Skin permeation enhancement composition for transdermal hormone delivery system
US8048919B2 (en) * 2004-06-28 2011-11-01 Archer Daniels Midland Company Use of ethyl lactate as an excipient for pharmaceutical compositions
JP5061519B2 (ja) 2006-07-12 2012-10-31 大正製薬株式会社 抗真菌剤含有o/wエマルション組成物
PL2191825T3 (pl) * 2007-08-27 2016-11-30 Środek przeciwko grzybiczemu zapaleniu skóry
NL2003711C2 (en) * 2009-10-27 2011-04-28 Shield Mark B V Aqueous composition for topical application, method of preparation, uses and device.
NL2003786C2 (en) * 2009-11-11 2010-07-30 Medner B V COMPOSITION FOR TOPICAL APPLICATION, USES THEREOF, APPLICATOR DEVICE AND KIT OF PARTS.
JP5362128B2 (ja) * 2011-01-30 2013-12-11 Meiji Seikaファルマ株式会社 外用抗真菌剤
EP2773333B1 (en) * 2011-11-04 2019-10-02 Agile Therapeutics, Inc. Dermal delivery compositions and methods
IN2015DN02377A (cg-RX-API-DMAC7.html) * 2012-09-14 2015-09-04 Pola Pharma Inc
JP6869637B2 (ja) * 2012-12-20 2021-05-12 ビュシャン,ラジブ 抗菌性組成物
JP6308137B2 (ja) * 2012-12-28 2018-04-11 大正製薬株式会社 皮膚適用製剤
CN103142458B (zh) * 2013-01-22 2015-09-09 莱普德制药有限公司 无成瘾性镇痛缓释递药系统的组方与制备方法
CN112999223A (zh) * 2013-11-22 2021-06-22 博世健康爱尔兰有限公司 抗感染的方法、组合物和装置
JP5623671B1 (ja) * 2014-07-23 2014-11-12 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
MY195201A (en) * 2015-09-18 2023-01-11 Kaken Pharma Co Ltd Biaryl Derivative and Medicine Containing Same
JP2017209136A (ja) 2016-05-23 2017-11-30 澁谷工業株式会社 電子線殺菌装置

Similar Documents

Publication Publication Date Title
JP2020011967A5 (cg-RX-API-DMAC7.html)
CA2645058C (en) Pharmaceutical composition for external use
DK2315581T3 (en) TOPICAL COMPOSITION FOR THE TREATMENT OF actinic keratosis
JP2019108388A5 (cg-RX-API-DMAC7.html)
TWI789448B (zh) 灰指甲治療用之外用製劑
JP5883886B2 (ja) 抗真菌組成物
JP5992324B2 (ja) 脂肪酸モノグリセリド組成物
JP2016503058A5 (cg-RX-API-DMAC7.html)
JP2016514121A5 (cg-RX-API-DMAC7.html)
JP2010519288A5 (cg-RX-API-DMAC7.html)
RU2017129893A (ru) Фармацевтическая композиция для местного применения
US10258560B1 (en) Composition for topical treatment of nail conditions
JP2016507540A (ja) 爪真菌症を治療するための局所用抗真菌薬組成物
JP2008534644A5 (ja) 2型糖尿病を治療または予防する組成物
JP5816881B2 (ja) 核酸を有効成分とする外用剤組成物
RU2015129081A (ru) Гелевые композиции
US20140142177A1 (en) Topical organic acid salt compositions suitable for treating infections
NZ797565B2 (en) 1-amino-1-cyclopropanecarboxylic acid hydrochloride formulations
JP2019043853A (ja) 経皮吸収促進剤、経皮吸収促進助剤、及び経皮製剤
JP2015134738A (ja) 皮膚真菌症治療剤